Breakdown | TTM | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 |
---|---|---|---|---|---|---|
Income Statement | ||||||
Total Revenue | 64.07B | 62.53B | 58.03B | 56.79B | 56.30B | 52.28B |
Gross Profit | 12.50B | 11.88B | 10.58B | 9.74B | 9.62B | 8.96B |
EBITDA | 8.27B | 3.96B | 4.34B | 3.49B | 3.91B | 3.01B |
Net Income | 4.02B | 2.99B | 1.61B | 1.61B | 1.40B | 934.00M |
Balance Sheet | ||||||
Total Assets | 73.83B | 76.54B | 73.03B | 68.05B | 66.19B | 66.86B |
Cash, Cash Equivalents and Short-Term Investments | 4.59B | 3.92B | 6.24B | 4.48B | 3.26B | 2.23B |
Total Debt | 2.49B | 3.57B | 1.38B | 1.45B | 833.82M | 1.94B |
Total Liabilities | 28.49B | 30.49B | 30.12B | 27.39B | 27.02B | 27.65B |
Stockholders Equity | 45.06B | 45.86B | 42.82B | 40.59B | 39.12B | 39.17B |
Cash Flow | ||||||
Free Cash Flow | 0.00 | -1.14B | 2.44B | 1.14B | 2.82B | 1.48B |
Operating Cash Flow | 0.00 | 1.04B | 5.78B | 3.07B | 4.30B | 2.76B |
Investing Cash Flow | 0.00 | -4.04B | -3.40B | -1.81B | -1.59B | -1.59B |
Financing Cash Flow | 0.00 | 687.22M | -666.53M | 27.31M | -1.67B | -1.02B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
---|---|---|---|---|---|---|---|
83 Outperform | ¥12.88B | 10.44 | 1.38% | 8.41% | 3.21% | ||
82 Outperform | ¥21.71B | 8.85 | 3.20% | 8.26% | -23.43% | ||
77 Outperform | ¥10.77B | 11.80 | 2.47% | 7.00% | -28.12% | ||
76 Outperform | ¥17.63B | 10.99 | 2.69% | 9.52% | 17.71% | ||
72 Outperform | ¥19.48B | 12.45 | 4.20% | 3.78% | -2.21% | ||
63 Neutral | ¥2.81B | 14.08 | 6.21% | 2.82% | -140.06% | ||
61 Neutral | $17.92B | 12.81 | -3.11% | 2.97% | 1.30% | -14.28% |